Company intelligence / Profile preview

Deep Lens

Columbus, Ohio, United States

Ownership: Private
Development stage: Other

Overview

Deep Lens offers the VIPER platform, which leverages artificial intelligence to optimize and accelerate recruitment of cancer patients for clinical trials by integrating and analyzing EMR, lab, pathology, and genomic data at the time of diagnosis, expanding trial access and compressing study timelines. It is deployed in numerous community oncology practices and is partnered with major CROs to improve site selection and recruitment efficiency[1][3][4][5][6][8].

Therapeutic areas: Oncology
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Worldwide Clinical TrialsPrecision for MedicineSouthern Oncology SpecialistsThe CenterTXPacific Cancer Care

Beyond the preview

Go deeper on Deep Lens.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deep Lens.

Explore the full profile